Tech Company Financing Transactions
Carigent Therapeutics Funding Round
Carigent Therapeutics, based in New Haven, secured $1 million in funding from Saint Simeon Marketing And Investments Lda..
Transaction Overview
Company Name
Announced On
12/11/2007
Transaction Type
Venture Equity
Amount
$1,000,000
Round
Series A
Investors
Saint Simeon Marketing And Investments Lda. (Stefano Ferrari)
Proceeds Purpose
The company plans to use the proceeds to further develop its nanotechnology platform, improve laboratory production capabilities and advance its lead therapeutic product candidates toward clinical studies.
Company Information
Company Status
Out of Business
Industry
Nanotechnology
Mailing Address
5 Science Park 13
New Haven, CT 06520
USA
New Haven, CT 06520
USA
Phone
Website
Email Address
Overview
Carigent Therapeutics is a drug delivery company focused on the development and commercialization of innovative medical treatments utilizing its proprietary drug delivery technologies.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
President
Seth Feuerstein
VP - Operations
Margaret Cartiera
Browse more venture capital transactions:
Prev: 12/11/2007: REVShare venture capital transaction
Next: 12/12/2007: Cleversafe venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs